Top Industry Leaders in the Nanomedical Devices Market
Latest Nanomedical devices Companies Updates:
Johnson & Johnson Acquired a nanomedicine startup developing targeted cancer therapies with enhanced efficacy and reduced side effects.Partnered with academic institutions to explore the use of nanorobots for minimally invasive surgery and drug delivery.
Abbott Laboratories Received FDA approval for their first nanomedical device, a bioresorbable drug-eluting stent coated with a nanocomposite material, offering improved long-term outcomes for patients with coronary artery disease.Focused on developing nanomedical implants and diagnostic tools for various chronic diseases.
Boston Scientific Corporation Collaborated with a research consortium to develop a nanomedical platform for targeted delivery of gene therapy vectors for treating genetic disorders.Emphasized their commitment to leveraging nanotechnology for innovative solutions in interventional cardiology and other therapeutic areas.
NanoCarrier Successfully completed Phase 2 clinical trials for their nanoparticle-based cancer drug delivery system, demonstrating improved tumor targeting and reduced side effects compared to conventional therapies.Partnered with pharmaceutical companies to bring their nanotechnology platform to the market for various drug delivery applications.
Medtronic Launched their next-generation implantable deep brain stimulation (DBS) device with nanoengineered electrodes, offering more precise stimulation and potentially improving treatment outcomes for neurological disorders.Invested in startups developing nanomedical sensors and devices for remote patient monitoring and personalized healthcare.
List of Nanomedical devices Key companies in the market
- Sanofi
- Pfizer Inc
- Celgene Corporation.
- Luminex Corporation
- Taiwan Liposome Company Ltd
- Merck & Co. Inc.
- Nanobiotix
- Starpharma Holdings Limited
- CYTIMMUNE SCIENCES INC.